Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2020 | 1 |
2021 | 2 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy.
J Immunother Cancer. 2023 Aug;11(8):e006847. doi: 10.1136/jitc-2023-006847.
J Immunother Cancer. 2023.
PMID: 37586765
Free PMC article.
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy.
Chamberlain CA, Bennett EP, Kverneland AH, Svane IM, Donia M, Met Ö.
Chamberlain CA, et al. Among authors: kverneland ah.
Mol Ther Oncolytics. 2022 Jan 10;24:417-428. doi: 10.1016/j.omto.2022.01.004. eCollection 2022 Mar 17.
Mol Ther Oncolytics. 2022.
PMID: 35141398
Free PMC article.
Item in Clipboard
Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types.
Kverneland AH, Chamberlain CA, Borch TH, Nielsen M, Mørk SK, Kjeldsen JW, Lorentzen CL, Jørgensen LP, Riis LB, Yde CW, Met Ö, Donia M, Svane IM.
Kverneland AH, et al.
J Immunother Cancer. 2021 Oct;9(10):e003499. doi: 10.1136/jitc-2021-003499.
J Immunother Cancer. 2021.
PMID: 34607899
Free PMC article.
Item in Clipboard
Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer.
Kverneland AH, Pedersen M, Westergaard MCW, Nielsen M, Borch TH, Olsen LR, Aasbjerg G, Santegoets SJ, van der Burg SH, Milne K, Nelson BH, Met Ö, Donia M, Svane IM.
Kverneland AH, et al.
Oncotarget. 2020 Jun 2;11(22):2092-2105. doi: 10.18632/oncotarget.27604. eCollection 2020 Jun 2.
Oncotarget. 2020.
PMID: 32547707
Free PMC article.
Item in Clipboard
Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma.
Borch TH, Harbst K, Rana AH, Andersen R, Martinenaite E, Kongsted P, Pedersen M, Nielsen M, Kjeldsen JW, Kverneland AH, Lauss M, Hölmich LR, Hendel H, Met Ö, Jönsson G, Donia M, Svane IM.
Borch TH, et al. Among authors: kverneland ah.
J Immunother Cancer. 2021 Jul;9(7):e002703. doi: 10.1136/jitc-2021-002703.
J Immunother Cancer. 2021.
PMID: 34210820
Free PMC article.
Item in Clipboard
Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study.
Streitz M, Miloud T, Kapinsky M, Reed MR, Magari R, Geissler EK, Hutchinson JA, Vogt K, Schlickeiser S, Kverneland AH, Meisel C, Volk HD, Sawitzki B.
Streitz M, et al. Among authors: kverneland ah.
Transplant Res. 2013 Oct 25;2(1):17. doi: 10.1186/2047-1440-2-17.
Transplant Res. 2013.
PMID: 24160259
Free PMC article.
Item in Clipboard
Cite
Cite